Cargando…
A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeabilit...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881332/ https://www.ncbi.nlm.nih.gov/pubmed/34987204 http://dx.doi.org/10.1038/s41366-021-01039-2 |
_version_ | 1784659450152353792 |
---|---|
author | Tilves, Curtis Yeh, Hsin-Chieh Maruthur, Nisa Juraschek, Stephen P. Miller, Edgar Appel, Lawrence J. Mueller, Noel T. |
author_facet | Tilves, Curtis Yeh, Hsin-Chieh Maruthur, Nisa Juraschek, Stephen P. Miller, Edgar Appel, Lawrence J. Mueller, Noel T. |
author_sort | Tilves, Curtis |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeability to lipopolysaccharides is unknown. This study’s objective was to determine the effects of a behavioral weight loss intervention or metformin treatment on plasma LBP. SUBJECTS/METHODS: SPIRIT was a randomized trial of adults with overweight or obesity. Participants were randomized to one of three arms: metformin treatment, coach-directed behavioral weight loss on a DASH diet, or self-directed care (control). Of 121 participants, a random subset (n=88) was selected to have LBP measured at baseline, 6-months, and 12-months post intervention. Intervention effects on LBP over time were assessed using generalized estimating equations (GEE). We also examined whether the intervention effects were modified by change in diet and weight. RESULTS: Arms were balanced by sex (83% female), race (51% white), and age (mean 60 years), with no differences in baseline LBP (median 4.23 μg/mL). At 1 year, mean weight change was −3.00% in the metformin arm, −3.02% in the coach-directed behavioral weight-loss arm, and +0.33% in the self-directed (control) arm. The corresponding change in LBP was +1.03, −0.98, +1.03 μg/mL. The behavioral weight-loss reduced LBP compared to self-directed care (β=−0.17, 95% CI: −0.33 to −0.01); no other between-arm comparisons were significant. Participants who reduced dietary fat showed the greatest reductions in 6-month LBP (β=−2.84, 95% CI: −5.17 to −0.50). CONCLUSIONS: Despite similar weight loss in the behavioral weight loss and metformin arms, only the behavioral weight loss intervention reduced LBP compared to control. Lifestyle weight loss interventions that promote a DASH diet may be effective at reducing gut barrier permeability to lipopolysaccharides. |
format | Online Article Text |
id | pubmed-8881332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-88813322022-07-06 A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial Tilves, Curtis Yeh, Hsin-Chieh Maruthur, Nisa Juraschek, Stephen P. Miller, Edgar Appel, Lawrence J. Mueller, Noel T. Int J Obes (Lond) Article BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeability to lipopolysaccharides is unknown. This study’s objective was to determine the effects of a behavioral weight loss intervention or metformin treatment on plasma LBP. SUBJECTS/METHODS: SPIRIT was a randomized trial of adults with overweight or obesity. Participants were randomized to one of three arms: metformin treatment, coach-directed behavioral weight loss on a DASH diet, or self-directed care (control). Of 121 participants, a random subset (n=88) was selected to have LBP measured at baseline, 6-months, and 12-months post intervention. Intervention effects on LBP over time were assessed using generalized estimating equations (GEE). We also examined whether the intervention effects were modified by change in diet and weight. RESULTS: Arms were balanced by sex (83% female), race (51% white), and age (mean 60 years), with no differences in baseline LBP (median 4.23 μg/mL). At 1 year, mean weight change was −3.00% in the metformin arm, −3.02% in the coach-directed behavioral weight-loss arm, and +0.33% in the self-directed (control) arm. The corresponding change in LBP was +1.03, −0.98, +1.03 μg/mL. The behavioral weight-loss reduced LBP compared to self-directed care (β=−0.17, 95% CI: −0.33 to −0.01); no other between-arm comparisons were significant. Participants who reduced dietary fat showed the greatest reductions in 6-month LBP (β=−2.84, 95% CI: −5.17 to −0.50). CONCLUSIONS: Despite similar weight loss in the behavioral weight loss and metformin arms, only the behavioral weight loss intervention reduced LBP compared to control. Lifestyle weight loss interventions that promote a DASH diet may be effective at reducing gut barrier permeability to lipopolysaccharides. 2022-03 2022-01-06 /pmc/articles/PMC8881332/ /pubmed/34987204 http://dx.doi.org/10.1038/s41366-021-01039-2 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms |
spellingShingle | Article Tilves, Curtis Yeh, Hsin-Chieh Maruthur, Nisa Juraschek, Stephen P. Miller, Edgar Appel, Lawrence J. Mueller, Noel T. A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial |
title | A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial |
title_full | A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial |
title_fullStr | A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial |
title_full_unstemmed | A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial |
title_short | A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial |
title_sort | behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: results from the spirit randomized trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881332/ https://www.ncbi.nlm.nih.gov/pubmed/34987204 http://dx.doi.org/10.1038/s41366-021-01039-2 |
work_keys_str_mv | AT tilvescurtis abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT yehhsinchieh abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT maruthurnisa abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT juraschekstephenp abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT milleredgar abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT appellawrencej abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT muellernoelt abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT tilvescurtis behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT yehhsinchieh behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT maruthurnisa behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT juraschekstephenp behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT milleredgar behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT appellawrencej behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial AT muellernoelt behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial |